We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
-3.62%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$367M
AUM Growth
-$21M
Cap. Flow
-$20.3M
Cap. Flow %
-5.53%
Top 10 Hldgs %
70.94%
Holding
38
New
2
Increased
6
Reduced
17
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 35.88%
2 Utilities 30.27%
3 Industrials 12.87%
4 Communication Services 6.7%
5 Financials 5.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHAL.B icon
1
U-Haul Holding Co Series N
UHAL.B
$12.2B
$33.2M 9.05%
640,530
-20,000
-3% -$1.13M
MRK icon
2
Merck
MRK
$315B
$32M 8.71%
300,372
-2,328
-0.8% -$251K
ABBV icon
3
AbbVie
ABBV
$450B
$30.6M 8.33%
191,743
-10,757
-5% -$1.64M
NEE icon
4
NextEra Energy
NEE
$185B
$26.6M 7.25%
345,114
-2,386
-0.7% -$183K
CMS icon
5
CMS Energy
CMS
$22.8B
$25.6M 6.97%
416,755
-1,745
-0.4% -$107K
DUK icon
6
Duke Energy
DUK
$97.5B
$25.1M 6.84%
260,319
-881
-0.3% -$87K
XEL icon
7
Xcel Energy
XEL
$49.2B
$25.1M 6.83%
371,754
-746
-0.2% -$50.3K
PFE icon
8
Pfizer
PFE
$143B
$22M 5.99%
538,626
-4,074
-0.8% -$176K
T icon
9
AT&T
T
$152B
$21.8M 5.93%
1,130,254
-1,746
-0.2% -$33.4K
ALL icon
10
Allstate
ALL
$64.3B
$18.5M 5.04%
166,844
-11,456
-6% -$1.45M
ABT icon
11
Abbott
ABT
$175B
$16.9M 4.6%
166,843
-757
-0.5% -$79.9K
AAPL icon
12
Apple
AAPL
$4.9T
$10.5M 2.87%
63,801
-699
-1% -$103K
IIIN icon
13
Insteel Industries
IIIN
$602M
$9.55M 2.6%
343,423
+69,423
+25% +$2.02M
AVA icon
14
Avista
AVA
$3.45B
$8.7M 2.37%
205,000
BHC icon
15
Bausch Health
BHC
$1.8B
$7.5M 2.04%
925,780
-5,220
-0.6% -$41.9K
FOCL
16
EDAP TMS S.A.
FOCL
$204M
$6.26M 1.71%
565,652
UHAL icon
17
U-Haul Holding Co
UHAL
$13.9B
$4.46M 1.22%
74,764
-291
-0.4% -$18.3K
PRTK
18
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3.95M 1.08%
1,556,247
-1,065
-0.1% -$2.1K
NEM icon
19
Newmont
NEM
$95.8B
$3.22M 0.88%
65,600
+600
+0.9% +$29.1K
SUPN icon
20
Supernus Pharmaceuticals
SUPN
$2.79B
$2.97M 0.81%
82,105
-10,000
-11% -$385K
KOD icon
21
Kodiak Sciences
KOD
$2.67B
$2.93M 0.8%
+473,000
New +$3.31M
SIRI icon
22
SiriusXM
SIRI
$10.3B
$2.61M 0.71%
65,784
ASH icon
23
Ashland
ASH
$3.14B
$1.54M 0.42%
15,000
FATE icon
24
Fate Therapeutics
FATE
$324M
$1.14M 0.31%
200,000
+143,000
+251% +$863K
LVTX
25
DELISTED
LAVA Therapeutics
LVTX
$1.12M 0.3%
671,874
+571,874
+572% +$1.6M

Similar funds

Bruce & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Bruce & Co held 38 positions worth $367M, down 5.4% from $388M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bruce & Co withdrew a net $20.3M in Q1 2023, closing 1 position and reducing 17 holdings. Its most notable exit was Amryt Pharma plc American Depositary Shares, an estimated $2.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 36% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co opened a new position in Kodiak Sciences worth $2.93M.

  • Bruce & Co's largest Q1 2023 buy was Kodiak Sciences: 473,000 shares worth $2.93M.
  • Bruce & Co added most to Insteel Industries in Q1 2023, an estimated $2.02M increase.
  • Bruce & Co's biggest Q1 2023 reduction was AbbVie, cutting an estimated $1.64M.
  • Bruce & Co fully exited Amryt Pharma plc American Depositary Shares in Q1 2023, selling an estimated $2.3M.
  • Bruce & Co's ten largest holdings make up 71% of its $367M portfolio in Q1 2023.
  • Bruce & Co opened 2 new positions and closed 1 in Q1 2023.
  • Bruce & Co's portfolio value fell 5.4% quarter-over-quarter to $367M.

Based on Bruce & Co's 13F filing for Q1 2023, filed 12 May 2023.